Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Paracoccidioidomycosis: an update

E Brummer1, E Castaneda, A Restrepo

  • 1Department of Medicine, California Institute for Medical Research, Santa Clara Valley Medical Center, San Jose 95128.

Clinical Microbiology Reviews
|April 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy of cement restrictors: Experimental study and development of a classification.

Revista espanola de cirugia ortopedica y traumatologia·2022
Same author

Development of an electrochemical impedimetric immunosensor for Corticotropin Releasing Hormone (CRH) using half-antibody fragments as elements of biorecognition.

Biosensors & bioelectronics·2019
Same author

G protein βγ subunits play a critical role in the actions of amphetamine.

Translational psychiatry·2019
Same author

Clinical and Health Care Utilization Outcomes of Kidney Transplantation in HIV-Positive Recipients: A Nationwide Analysis From 2008-2013.

Transplantation proceedings·2018
Same author

Searching for the best agent for antibiotic prophylaxis in patients undergoing transcatheter aortic valve implantation.

The Journal of hospital infection·2018
Same author

Endoscopic Treatment for Vesicoureteral Reflux in Recurrent Urinary Tract Infections in Kidney Transplant: Experience of One Center.

Transplantation proceedings·2018

This review details paracoccidioidomycosis, focusing on fungal dimorphism, host immune responses, and diagnostic advancements. It highlights challenges in treating this serious fungal infection, particularly pulmonary fibrosis.

Area of Science:

  • Mycology
  • Immunology
  • Infectious Diseases

Background:

  • Paracoccidioidomycosis is a systemic fungal infection caused by Paracoccidioides brasiliensis.
  • The fungus exhibits thermal dimorphism, transitioning between mycelial and yeast phases, with yeast forms being infectious.

Purpose of the Study:

  • To review current knowledge on paracoccidioidomycosis, encompassing fungal biology, host-pathogen interactions, diagnostics, and therapeutics.
  • To highlight advancements in understanding the disease, including the identification of key antigens and immune response alterations.

Main Methods:

  • Review of existing literature on paracoccidioidomycosis.
  • Analysis of fungal dimorphism, hormonal influences, and immune responses.
  • Evaluation of diagnostic tools and therapeutic strategies.

Related Experiment Videos

Main Results:

  • The 43-kDa glycoprotein (Gp43) antigen has been identified, aiding serologic test development.
  • Severe disease is linked to depressed cell-mediated immunity and a reduced CD4/CD8 ratio.
  • Itraconazole is the current drug of choice, though pulmonary fibrosis remains a significant sequela.

Conclusions:

  • Understanding fungal dimorphism and host immunity is crucial for managing paracoccidioidomycosis.
  • Diagnostic and therapeutic strategies have improved, but long-term complications persist.
  • Further research is needed to address treatment challenges and sequelae like pulmonary fibrosis.